Actively Recruiting
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Led by Mayo Clinic · Updated on 2025-07-18
300
Participants Needed
3
Research Sites
170 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This study evaluates if AI can be used with transvaginal ultrasound images for early detection of endometrial cancer or premalignant lesions.
CONDITIONS
Official Title
Non-Invasive Identification of Endometrial Cancer/Endometrial Atypical Hyperplasia With an AI-Based Classifier Applied to Transvaginal Ultrasound in Patients With Post-Menopausal Bleeding
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Age 55 years or older
- At least one episode of postmenopausal bleeding
- Endometrial biopsy available from Mayo Clinic (MN, AZ, FL), Mayo Clinic Health System, or an external institution
- Willingness to participate in the study
You will not qualify if you...
- Diagnostic tests performed more than 90 days apart
- Physical inability or refusal to undergo transvaginal ultrasound
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 3 locations
1
Mayo Clinic in Arizona
Scottsdale, Arizona, United States, 85259
Actively Recruiting
2
Mayo Clinic in Florida
Jacksonville, Florida, United States, 32224-9980
Actively Recruiting
3
Mayo Clinic in Rochester
Rochester, Minnesota, United States, 55905
Actively Recruiting
Research Team
C
Clinical Trials Referral Office
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
1
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here